What is OMMBID?
Scriver's OMMBID from McGraw-Hill Medical is an essential online resource delivering comprehensive coverage of the genes and genetic mechanisms underlying human disease states. Based on the world’s most respected book on the subject, Metabolic and Molecular Bases of Inherited Disease, first published in 1960, Scriver's OMMBID is an indispensable digital reference tool that provides geneticists, researchers, students, clinicians, and fellows involved with the causation and treatment of inherited diseases -- with cutting edge information spanning the entire field of genetics.
Much more than a literature synopsis, OMMBID
provides the latest knowledge on the metabolic and molecular underpinnings of a growing list of inherited diseases – as well as updates on pathophysiology and treatment.
’s distinguished editorial board
, led by Editor-in-Chief, David Valle, MD of The Johns Hopkins University School of Medicine, guides the site’s content. This internationally acclaimed team of researchers, geneticists, educators, and clinicians imparts both depth and breadth within a coherent organ-system based framework.
Why is OMMBID unique?
provides encyclopedic coverage of a host of human disorders from the genetic variation to the clinical descriptions and treatment – through these unique interactive features:
Exclusive text availability–Scriver's OMMBID is the only place that offers the complete four-volume text of the definitive resource on the causation and treatment of inherited diseases, The Metabolic and Molecular Bases of Inherited Diseases. In addition, we've added Clinical Genomics to OMMBID. While traditional textbooks on medical genetics focus on classic Mendelian disorders, Clinical Genomics discusses the everyday application of genetic assessment and the diagnostic, therapeutic, and preventive implications to the most common adult diseases that healthcare providers encounter. Covering approximately 200 conditions, it is a true clinical text.
– Supplemental updates and chapters are continually added to reflect new developments in the field.
New chapters and sections
– Stay current with recent developments in cancer genetics, mitochondrial disease, lysosomal enzyme therapy, along with chapters on missense mutations, misfolding of proteins, and chaperones in the pathogenesis of phenotypes.
High quality full-color images
– Includes thousands of images and complex illustrations of topics such as protein interactions, clinical presentations, and genetic modeling that will assist in visual diagnosis, research, and step-by-step procedures.
– The seminal chapter contributed by leading geneticist Jean-Marie Saudubray offers concise diagnoses and algorithms for diagnosing highly specific syndromes and systems.
The OMMBID Blog
-- A dedicated board of vetted researchers post upwards of 10 entries a month, regarding the latest findings across a variety of fields.
Trademarks: The McGraw-Hill Education logo, OMMBID, and related trade dress are trademarks or registered trademarks of McGraw-Hill Education and/or its affiliates in the United States and other countries, and may not be used without written permission. All other trademarks are the property of their respective owners. McGraw-Hill Education is not associated with any products or vendor mentioned in OMMBID.
Copyright © McGraw-Hill Education. All rights reserved.